177 related articles for article (PubMed ID: 35364436)
1. NSD2 activates the E2F transcription factor 1/Y-box binding protein 2 axis to promote the malignant development of oral squamous cell carcinoma.
Zhang L; Hu G
Arch Oral Biol; 2022 Jun; 138():105412. PubMed ID: 35364436
[TBL] [Abstract][Full Text] [Related]
2. Tumor Promoting Role of NRIP1 in Oral Squamous Cell Carcinoma: The Involvement of NSD2-Mediated Histone Methylation of DGCR8.
Zhang L; Hu G
Tohoku J Exp Med; 2023 Jul; 260(3):193-204. PubMed ID: 37045786
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
Niu X; Yang B; Liu F; Fang Q
Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
[TBL] [Abstract][Full Text] [Related]
4. Exosomal-mediated transfer of APCDD1L-AS1 induces 5-fluorouracil resistance in oral squamous cell carcinoma via miR-1224-5p/nuclear receptor binding SET domain protein 2 (NSD2) axis.
Li S; Shi Z; Fu S; Li Q; Li B; Sang L; Wu D
Bioengineered; 2021 Dec; 12(1):7188-7204. PubMed ID: 34546854
[TBL] [Abstract][Full Text] [Related]
5. LINC00958 regulated miR-627-5p/YBX2 axis to facilitate cell proliferation and migration in oral squamous cell carcinoma.
Chen F; Liu M; Yu Y; Sun Y; Li J; Hu W; Wang X; Tong D
Cancer Biol Ther; 2019; 20(9):1270-1280. PubMed ID: 31161900
[TBL] [Abstract][Full Text] [Related]
6. SNHG12/miR-326/E2F1 feedback loop facilitates the progression of oral squamous cell carcinoma.
Yin Y; Tan Y; Yao Y; Lu N; Zhang F
Oral Dis; 2020 Nov; 26(8):1631-1639. PubMed ID: 32506729
[TBL] [Abstract][Full Text] [Related]
7. LINC00173 blocks GATA6-mediated transcription of COL5A1 to affect malignant development of oral squamous cell carcinoma.
Dong C; Zhao Y; Yang S; Jiao X
J Oral Pathol Med; 2023 Jul; 52(6):493-503. PubMed ID: 36856154
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
[TBL] [Abstract][Full Text] [Related]
9. Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer.
Zhao LH; Li Q; Huang ZJ; Sun MX; Lu JJ; Zhang XH; Li G; Wu F
Cell Death Dis; 2021 Oct; 12(11):974. PubMed ID: 34671018
[TBL] [Abstract][Full Text] [Related]
10. MiR-4282 inhibits tumor progression through down-regulation of ZBTB2 by targeting LIN28B in oral squamous cell carcinoma.
Zhang Y; Zhang Z; Huang W; Zeng J
J Cell Physiol; 2020 Nov; 235(11):8035-8047. PubMed ID: 31970774
[TBL] [Abstract][Full Text] [Related]
11. DDX27 regulates oral squamous cell carcinoma development through targeting CSE1L.
Li G; Li R; Wang W; Sun M; Wang X
Life Sci; 2024 Mar; 340():122479. PubMed ID: 38301874
[TBL] [Abstract][Full Text] [Related]
12. HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis.
Li W; Zhu Q; Zhang S; Liu L; Zhang H; Zhu D
Oral Oncol; 2020 Dec; 111():104946. PubMed ID: 32763778
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition.
Han X; Piao L; Yuan X; Wang L; Liu Z; He X
Int J Med Sci; 2019; 16(10):1404-1411. PubMed ID: 31692936
[No Abstract] [Full Text] [Related]
14. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
15. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
[TBL] [Abstract][Full Text] [Related]
16. Identification of E2F transcription factor 7 as a novel potential biomarker for oral squamous cell carcinoma.
Zhou P; Xiao L; Xu X
Head Face Med; 2021 Feb; 17(1):7. PubMed ID: 33637098
[TBL] [Abstract][Full Text] [Related]
17. Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma.
He C; Liu C; Wang L; Sun Y; Jiang Y; Hao Y
Cell Death Dis; 2019 Jan; 10(2):65. PubMed ID: 30683853
[TBL] [Abstract][Full Text] [Related]
18. Cell division cycle 7 is a potential therapeutic target in oral squamous cell carcinoma and is regulated by E2F1.
Jin S; Ma H; Yang W; Ju H; Wang L; Zhang Z
J Mol Med (Berl); 2018 Jun; 96(6):513-525. PubMed ID: 29713760
[TBL] [Abstract][Full Text] [Related]
19. A PWWP Domain of Histone-Lysine N-Methyltransferase NSD2 Binds to Dimethylated Lys-36 of Histone H3 and Regulates NSD2 Function at Chromatin.
Sankaran SM; Wilkinson AW; Elias JE; Gozani O
J Biol Chem; 2016 Apr; 291(16):8465-74. PubMed ID: 26912663
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte elevated gene-1 promotes tumour growth and invasion by inducing EMT in oral squamous cell carcinoma.
Wang Y; Wang T; Sun Y; Sun W; Wang X
Sci Rep; 2017 Nov; 7(1):15447. PubMed ID: 29133850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]